Switch theme
Sign up to access all valuation multiples
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.
2020
769
LTM Revenue $316M
LTM EBITDA $15.5M
$399M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Beauty Health has a last 12-month revenue (LTM) of $316M and a last 12-month EBITDA of $15.5M.
In the most recent fiscal year, Beauty Health achieved revenue of $334M and an EBITDA of $14.5M.
Beauty Health expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Beauty Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $316M | XXX | $334M | XXX | XXX | XXX |
| Gross Profit | $190M | XXX | $182M | XXX | XXX | XXX |
| Gross Margin | 60% | XXX | 55% | XXX | XXX | XXX |
| EBITDA | $15.5M | XXX | $14.5M | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| EBIT | -$30.1M | XXX | -$67.8M | XXX | XXX | XXX |
| EBIT Margin | -10% | XXX | -20% | XXX | XXX | XXX |
| Net Profit | -$29.1M | XXX | -$29.1M | XXX | XXX | XXX |
| Net Margin | -9% | XXX | -9% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $182M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Beauty Health's stock price is $2.
Beauty Health has current market cap of $205M, and EV of $399M.
See Beauty Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $399M | $205M | XXX | XXX | XXX | XXX | $-0.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Beauty Health has market cap of $205M and EV of $399M.
Beauty Health's trades at 1.2x EV/Revenue multiple, and 27.5x EV/EBITDA.
Equity research analysts estimate Beauty Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Beauty Health has a P/E ratio of -7.0x.
See valuation multiples for Beauty Health and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $205M | XXX | $205M | XXX | XXX | XXX |
| EV (current) | $399M | XXX | $399M | XXX | XXX | XXX |
| EV/Revenue | 1.3x | XXX | 1.2x | XXX | XXX | XXX |
| EV/EBITDA | 25.7x | XXX | 27.5x | XXX | XXX | XXX |
| EV/EBIT | -13.3x | XXX | -5.9x | XXX | XXX | XXX |
| EV/Gross Profit | 2.1x | XXX | n/a | XXX | XXX | XXX |
| P/E | -7.0x | XXX | -7.0x | XXX | XXX | XXX |
| EV/FCF | 20.1x | XXX | 42.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialBeauty Health's last 12 month revenue growth is -6%
Beauty Health's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Beauty Health's rule of 40 is -19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Beauty Health's rule of X is -10% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Beauty Health and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | -6% | XXX | -4% | XXX | XXX | XXX |
| EBITDA Margin | 5% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Growth | 33% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -19% | XXX | -2% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | -10% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 35% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 75% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
| EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
| Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
| Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
| Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Beauty Health acquired XXX companies to date.
Last acquisition by Beauty Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Beauty Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Beauty Health founded? | Beauty Health was founded in 2020. |
| Where is Beauty Health headquartered? | Beauty Health is headquartered in United States of America. |
| How many employees does Beauty Health have? | As of today, Beauty Health has 769 employees. |
| Who is the CEO of Beauty Health? | Beauty Health's CEO is Ms. Marla Malcolm Beck. |
| Is Beauty Health publicy listed? | Yes, Beauty Health is a public company listed on NAS. |
| What is the stock symbol of Beauty Health? | Beauty Health trades under SKIN ticker. |
| When did Beauty Health go public? | Beauty Health went public in 2021. |
| Who are competitors of Beauty Health? | Similar companies to Beauty Health include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
| What is the current market cap of Beauty Health? | Beauty Health's current market cap is $205M |
| What is the current revenue of Beauty Health? | Beauty Health's last 12 months revenue is $316M. |
| What is the current revenue growth of Beauty Health? | Beauty Health revenue growth (NTM/LTM) is -6%. |
| What is the current EV/Revenue multiple of Beauty Health? | Current revenue multiple of Beauty Health is 1.3x. |
| Is Beauty Health profitable? | Yes, Beauty Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Beauty Health? | Beauty Health's last 12 months EBITDA is $15.5M. |
| What is Beauty Health's EBITDA margin? | Beauty Health's last 12 months EBITDA margin is 5%. |
| What is the current EV/EBITDA multiple of Beauty Health? | Current EBITDA multiple of Beauty Health is 25.7x. |
| What is the current FCF of Beauty Health? | Beauty Health's last 12 months FCF is $19.8M. |
| What is Beauty Health's FCF margin? | Beauty Health's last 12 months FCF margin is 6%. |
| What is the current EV/FCF multiple of Beauty Health? | Current FCF multiple of Beauty Health is 20.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
